MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
6.81
+0.04
+0.59%
After Hours: 6.82 +0.01 +0.15% 19:30 09/04 EDT
OPEN
6.78
PREV CLOSE
6.77
HIGH
6.87
LOW
6.72
VOLUME
3.76M
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
2.910
MARKET CAP
2.39B
P/E (TTM)
-15.6516
1D
5D
1M
3M
1Y
5Y
1D
Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...
Benzinga · 3d ago
Nuvation Bio (NUVB) Wins FDA Fast Track Status, Is The Stock Still Undervalued?
Simply Wall St · 4d ago
Does Nuvation Bio (NUVB) Have the Potential to Rally 91.92% as Wall Street Analysts Expect?
NASDAQ · 4d ago
Nuvation Bio to Participate in Upcoming Investor Conferences
PR Newswire · 5d ago
Weekly Report: what happened at NUVB last week (0824-0828)?
Weekly Report · 08/31 09:38
Nuvation: Why I'm Downgrading To Hold Despite Progress On NSCLC And Glioma Fronts
Seeking Alpha · 08/26 20:15
How Safusidenib’s FDA Fast Track Status Could Impact Nuvation Bio (NUVB) Investors
Simply Wall St · 08/26 05:25
Weekly Report: what happened at NUVB last week (0817-0821)?
Weekly Report · 08/24 09:39
More
About NUVB
Nuvation Bio Inc. is a global oncology company. The Company is focused on tackling cancer treatment. Its diverse pipeline includes taletrectinib (IBTROZI), a next-generation ROS1 inhibitor; safusidenib, a brain-penetrant IDH1 inhibitor, and a drug-drug conjugate (DDC) program. IBTROZI is an oral, potent, central nervous system-active, selective, next-generation ROS1 inhibitor. Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1 (mIDH1), which is detected in various tumors, including gliomas. Its platform leverages its drug discovery and chemistry expertise to find the minimum target binding sites of drug X and drug Y and fuse them together, while maintaining activity. Its DDCs are designed to selectively bind to intracellular as well as surface cell membrane targets that are expressed more highly in specific target tissues and to potently deliver anti-cancer warheads to these target tissues.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.